Related Experiment Video
Updated: Jul 3, 2026

Mouse Models for Graft Arteriosclerosis
Published on: May 14, 2013
Prevention and treatment of thrombosis in microvascular surgery
Matthew M Hanasono1, Charles E Butler
1Department of Plastic Surgery, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.
Abstract:
Microvascular free tissue transfer is associated with a 1 to 5% failure rate, most commonly as a result of thrombosis in the region of the vascular anastomosis or the distal flap microcirculation. Although many laboratory and clinical studies have been performed, there is no consensus on the efficacy and optimal dosage of various pharmacological agents available for the prevention and treatment of thrombosis in microvascular surgery. Some agents have potentially serious side effects; and all agents carry the risks of undesirable bleeding and hematoma formation. We review the current experimental and clinical evidence regarding the agents commonly used to prevent and treat thrombosis in microvascular surgery and make practical recommendations for the management of vascular compromise in free flaps.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Peripheral Artery Disease III: Interprofessional Care